cabotegravir sodium · Viiv Hlthcare · NDA 212887
Vocabria
Earliest generic entry, as listed
4 Feb 2031
Blocked by patent: US 8410103.
Listed patents · 1 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 8410103 | drug substance, drug product, use U-3348 · sets the listed date | 4 Feb 2031 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 212887 · 001 · RLD | tablet, oral | EQ 30MG BASE | 4 Feb 2031 |
Expired or delisted (2)
- US 10927129 · substance, product · 28 Apr 2026
- NCE · 21 Jan 2026